Combined Saussurea costus and doxorubicin suppresses breast cancer cell migration and proliferation through MMP2/MMP9 downregulation: in vitro and molecular docking evidence

Abstract Breast cancer (BC) is still a major cause of cancer-related death in women and requires new strategies for treatment. Saussurea costus (COS) has been reported to exhibit anticancer activity, and doxorubicin (DOX) is a commonly used chemotherapeutic agent. The relationship between their roles and BC cell behavior and regulation remains unclear. 28 compounds were identified in the COS ethanolic extract by LC–ESI–MS/MS. The docking and dynamics study of major compounds with MMP2 and MMP9 was performed. The effects of COS, DOX, and their combination on MCF7 and MDA-MB-231 cells were assessed for cytotoxicity, proliferation, migration (wound healing and transwell), colony formation, apoptosis (annexin-V), cell cycle, and MMP2/MMP9 mRNA expression. The main compounds found were apigenin (12.99%), medioresinol (8.32%), and luteolin (8.12%). Luteolin had the most negative value for protein binding (MMP2: − 8.90 kcal/mol; MMP9: − 9.50 kcal/mol) and medioresinol for mRNA binding. COS demonstrated dose-dependent cytotoxicity (IC 50 : 106.8 ± 1.43 μg/mL for MCF7; 116.8 ± 5.66 μg/mL for MDA-MB-231). The COS + DOX combination significantly reduced proliferation, migration, and colony formation, and increased apoptosis (MCF7: 34.85 ± 1.84%, MDA-MB-231: 45.56 ± 7.74%), and induced G2/M arrest in MDA-MB-231 cells. The expression of MMP2 and MMP9 mRNA was significantly downregulated. The COS + DOX treatment had a combinatorial effect in suppressing BC cell growth and migration, which was associated with downregulation of MMP2/MMP9 and induction of apoptosis. While these findings suggest a potential mechanistic role for MMP2/MMP9 downregulation, future studies measuring protein expression and enzymatic activity are required to confirm functional inhibition. Given its potential therapeutic significance, further in vivo studies are warranted.

Authors

Institutions

Publication Details

Journal
Scientific Reports
Published
2026-11-13
DOI
https://doi.org/10.1038/s41598-026-72010-2
Primary Topic
Medicinal Plant Research
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Combined Saussurea costus and doxorubicin suppresses breast cancer cell migration and proliferation through MMP2/MMP9 downregulation: in vitro and molecular docking evidence

Jehan A. Hasanen, Ahmed S. Warda, Engy Mohsen, Amany Elsayed Ragab et al.
1 links
Scientific Reports
Medicinal Plant Research
article

Combined Saussurea costus and doxorubicin suppresses breast cancer cell migration and proliferation through MMP2/MMP9 downregulation: in vitro and molecular docking evidence

Jehan A. Hasanen, Ahmed S. Warda, Engy Mohsen, Amany Elsayed Ragab, Mohamed Fathy Youssef, Ali El-Far
article en

Abstract

Abstract Breast cancer (BC) is still a major cause of cancer-related death in women and requires new strategies for treatment. Saussurea costus (COS) has been reported to exhibit anticancer activity, and doxorubicin (DOX) is a commonly used chemotherapeutic agent. The relationship between their roles and BC cell behavior and regulation remains unclear. 28 compounds were identified in the COS ethanolic extract by LC–ESI–MS/MS. The docking and dynamics study of major compounds with MMP2 and MMP9 was performed. The effects of COS, DOX, and their combination on MCF7 and MDA-MB-231 cells were assessed for cytotoxicity, proliferation, migration (wound healing and transwell), colony formation, apoptosis (annexin-V), cell cycle, and MMP2/MMP9 mRNA expression. The main compounds found were apigenin (12.99%), medioresinol (8.32%), and luteolin (8.12%). Luteolin had the most negative value for protein binding (MMP2: − 8.90 kcal/mol; MMP9: − 9.50 kcal/mol) and medioresinol for mRNA binding. COS demonstrated dose-dependent cytotoxicity (IC 50 : 106.8 ± 1.43 μg/mL for MCF7; 116.8 ± 5.66 μg/mL for MDA-MB-231). The COS + DOX combination significantly reduced proliferation, migration, and colony formation, and increased apoptosis (MCF7: 34.85 ± 1.84%, MDA-MB-231: 45.56 ± 7.74%), and induced G2/M arrest in MDA-MB-231 cells. The expression of MMP2 and MMP9 mRNA was significantly downregulated. The COS + DOX treatment had a combinatorial effect in suppressing BC cell growth and migration, which was associated with downregulation of MMP2/MMP9 and induction of apoptosis. While these findings suggest a potential mechanistic role for MMP2/MMP9 downregulation, future studies measuring protein expression and enzymatic activity are required to confirm functional inhibition. Given its potential therapeutic significance, further in vivo studies are warranted.

Scientific ReportsVol. 16(1)
Suez Canal University (EG), Cairo University (EG), Damanhour University (EG), Tanta University (EG)
Science and Technology Development Fund
Good health and well-being
Medicinal Plant Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon